XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 41.25

Change

-0.13 (-0.31)%

Market Cap

CAD 0.58B

Volume

1.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.90 (-0.65%)

CAD 21.09B
ZSP:CA BMO S&P 500

-0.55 (-0.64%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.41 (-0.70%)

CAD 11.46B
VUN:CA Vanguard US Total Market

-0.56 (-0.54%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

-0.26 (-0.53%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

-0.56 (-0.69%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

-0.64 (-0.70%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

-1.47 (-0.65%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

-0.33 (-0.57%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

-0.47 (-0.60%)

CAD 3.23B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.15% 9% A- 20% F
Dividend Return 0.20% 17% F 5% F
Total Return -7.95% 9% A- 20% F
Trailing 12 Months  
Capital Gain 9.85% 69% C- 69% C-
Dividend Return 1.02% 27% F 18% F
Total Return 10.87% 69% C- 64% D
Trailing 5 Years  
Capital Gain 88.36% 72% C 76% C+
Dividend Return 7.25% 21% F 10% F
Total Return 95.61% 63% D 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.27% 76% C+ 80% B-
Dividend Return 15.20% 74% C 78% C+
Total Return 0.93% 35% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.04% 38% F 54% F
Risk Adjusted Return 101.06% 60% D- 93% A
Market Capitalization 0.58B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.